ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Hiroshi Watanabe
Yuji Tachimori
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kato, H.
Right arrow Articles by Iizuka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kato, H.
Right arrow Articles by Iizuka, T.

Ann Thorac Surg 1991;51:931-935
© 1991 The Society of Thoracic Surgeons


Articles

Evaluation of neck lymph node dissection for thoracic esophageal carcinoma

Hoichi Kato, MD*, Hiroshi Watanabe, MD, Yuji Tachimori, MD, Toshifumi Iizuka, MD

Department of Surgery, National Cancer Center Hospital, and National Oji Hospital, Tokyo, Japan

Accepted for publication December 28, 1990.

* Address reprint requests to Dr Kato, National Cancer Center Hospital, 1-1 Tsukiji 5-Chome, Chuo-ku, Tokyo, 104, Japan.

We studied a series of 150 patients treated for thoracic esophageal carcinoma at our institution. The patients were divided into two matched groups. Group B underwent transthoracic esophagectomy with mediastinal and abdominal lymphadenectomy only; group A also underwent bilateral neck lymph node dissection. The rates of operative mortality and operative complications did not differ significantly between the two groups. The 5-year survival rate was 38.7% overall (48.7% in group A and 33.7% in group B). Group A had a significantly better survival curve than group B. Twenty patients (26.0%) in group A had metastasis in the dissected neck lymph nodes. The 4-year survival rate of these patients was 47.9%. The significantly better survival of group A and the satisfactory prognosis in the patients with positive cervical lymph nodes demonstrates the effectiveness of neck lymph node dissection in radical operation for thoracic esophageal carcinoma.




This article has been cited by other articles:


Home page
Anticancer ResHome page
T. YOKOTA, S. HATOOKA, T. URA, T. ABE, D. TAKAHARI, K. SHITARA, M. NOMURA, C. KONDO, A. MIZOTA, Y. YATABE, et al.
Docetaxel plus 5-Fluorouracil and Cisplatin (DCF) Induction Chemotherapy for Locally Advanced Borderline-resectable T4 Esophageal Cancer
Anticancer Res, October 1, 2011; 31(10): 3535 - 3541.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H.-J. Jang, H.-S. Lee, M. S. Kim, J. M. Lee, and J. I. Zo
Patterns of Lymph Node Metastasis and Survival for Upper Esophageal Squamous Cell Carcinoma
Ann. Thorac. Surg., September 1, 2011; 92(3): 1091 - 1097.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
T. SHIMAKAWA, Y. NARITAKA, S. ASAKA, N. ISOHATA, K. YAMAGUCHI, M. MURAYAMA, S. KONNO, T. KATSUBE, K. OGAWA, and H. IDE
A Case of Esophageal Cancer with Multiple Lymph Node Metastases which Responded to Neoadjuvant Chemotherapy (DCF therapy)
Anticancer Res, January 1, 2010; 30(1): 221 - 226.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
W.-T. Fang and W.-H. Chen
Current Trends in Extended Lymph Node Dissection for Esophageal Carcinoma
Asian Cardiovasc Thorac Ann, April 1, 2009; 17(2): 208 - 213.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
M. Tachibana, S. Kinugasa, N. Hirahara, and H. Yoshimura
Lymph node classification of esophageal squamous cell carcinoma and adenocarcinoma
Eur J Cardiothorac Surg, August 1, 2008; 34(2): 427 - 431.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
T. Kii, H. Takiuchi, S. Kawabe, M. Gotoh, S. Ohta, T. Tanaka, S. Kuwakado, H. Nishitani, and K.-i. Katsu
Evaluation of Prognostic Factors of Esophageal Squamous Cell Carcinoma (Stage II III) After Concurrent Chemoradiotherapy Using Biopsy Specimens
Jpn. J. Clin. Oncol., August 20, 2007; (2007) hym077v1.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
Y. Ueda, A. Shiozaki, H. Itoi, K. Okamoto, H. Fujiwara, D. Ichikawa, S. Kikuchi, N. Fuji, T. Itoh, T. Ochiai, et al.
The Range of Tumor Extension Should Have Precedence over the Location of the Deepest Tumor Center in Determining the Regional Lymph Node Grouping for Widely Extending Esophageal Carcinomas
Jpn. J. Clin. Oncol., December 1, 2006; 36(12): 775 - 782.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Mimura, K. Kono, M. Hanawa, M. Kanzaki, A. Nakao, A. Ooi, and H. Fujii
Trastuzumab-Mediated Antibody-Dependent Cellular Cytotoxicity against Esophageal Squamous Cell Carcinoma
Clin. Cancer Res., July 1, 2005; 11(13): 4898 - 4904.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. Z. Atkins, A. S. Shah, K. A. Hutcheson, J. H. Mangum, T. N. Pappas, D. H. Harpole Jr, and T. A. D'Amico
Reducing Hospital Morbidity and Mortality Following Esophagectomy
Ann. Thorac. Surg., October 1, 2004; 78(4): 1170 - 1176.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
M. Koshy, N. Esiashvilli, J. C. Landry, C. R. Thomas Jr., and R. H. Matthews
Multiple Management Modalities in Esophageal Cancer: Epidemiology, Presentation and Progression, Work-up, and Surgical Approaches
Oncologist, April 1, 2004; 9(2): 137 - 146.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
M. Tachibana, S. Kinugasa, H. Yoshimura, D. K. Dhar, and N. Nagasue
Extended Esophagectomy With 3-Field Lymph Node Dissection for Esophageal Cancer
Arch Surg, December 1, 2003; 138(12): 1383 - 1389.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. Fang, H. Kato, Y. Tachimori, H. Igaki, H. Sato, and H. Daiko
Analysis of pulmonary complications after three-field lymph node dissection for esophageal cancer
Ann. Thorac. Surg., September 1, 2003; 76(3): 903 - 908.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
K. Hayashi, N. Ando, H. Watanabe, H. Ide, K. Nagai, N. Aoyama, W. Takiyama, K. Ishida, K. Isono, H. Makuuchi, et al.
Phase II Evaluation of Protracted Infusion of Cisplatin and 5-Fluorouracil in Advanced Squamous Cell Carcinoma of the Esophagus: a Japan Esophageal Oncology Group (JEOG) Trial (JCOG9407)
Jpn. J. Clin. Oncol., September 1, 2001; 31(9): 419 - 423.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. Fang, H. Igaki, Y. Tachimori, H. Sato, H. Daiko, and H. Kato
Three-field lymph node dissection for esophageal cancer in elderly patients over 70 years of age
Ann. Thorac. Surg., September 1, 2001; 72(3): 867 - 871.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
H. Igaki, H. Kato, Y. Tachimori, H. Sato, H. Daiko, and Y. Nakanishi
Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection
Eur J Cardiothorac Surg, June 1, 2001; 19(6): 887 - 893.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
W. Fang, H. Kato, W. Chen, Y. Tachimori, H. Igaki, and H. Sato
Comparison of Surgical Management of Thoracic Esophageal Carcinoma Between Two Referral Centers in Japan and China
Jpn. J. Clin. Oncol., May 1, 2001; 31(5): 203 - 208.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
T. Lerut, W. Coosemans, P. De Leyn, G. Decker, G. Deneffe, and D. Van Raemdonck
Is there a role for radical esophagectomy
Eur J Cardiothorac Surg, September 1, 1999; 16(Supplement_1): S44 - S47.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
C. van de Ven, P. De Leyn, W. Coosemans, D. Van Raemdonck, and T. Lerut
Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction{star}
Eur J Cardiothorac Surg, June 1, 1999; 15(6): 769 - 773.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
S. Nakano, M. Baba, M. Shimada, K. Shirao, Y. Noguchi, C. Kusano, S. Natsugoe, H. Yoshinaka, T. Fukumoto, and T. Aikou
How the Lymph Node Metastases Toward Cervico-Upper Mediastinal Region Affect the Outcome of Patients with Carcinoma of the Thoracic Esophagus
Jpn. J. Clin. Oncol., May 1, 1999; 29(5): 248 - 251.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Tabira, T. Okuma, K. Kondo, and N. Kitamura
INDICATIONS FOR THREE-FIELD DISSECTION FOLLOWED BY ESOPHAGECTOMY FOR ADVANCED CARCINOMA OF THE THORACIC ESOPHAGUS
J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 239 - 245.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Tachimori, H. Kato, and H. Watanabe
SURGERY FOR THORACIC ESOPHAGEAL CARCINOMA WITH CLINICALLY POSITIVE CERVICAL NODES
J. Thorac. Cardiovasc. Surg., December 1, 1998; 116(6): 954 - 959.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Lerut
Esophageal surgery at the end of the millennium
J. Thorac. Cardiovasc. Surg., July 1, 1998; 116(1): 1 - 20.
[Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. H. Ellis Jr., G. J. Heatley, M. J. Krasna, W. A. Williamson, and K. Balogh
ESOPHAGOGASTRECTOMY FOR CARCINOMA OF THE ESOPHAGUS AND CARDIA: A COMPARISON OF FINDINGS AND RESULTS AFTER STANDARD RESECTION IN THREE CONSECUTIVE EIGHT-YEAR INTERVALS WITH IMPROVED STAGING CRITERIA
J. Thorac. Cardiovasc. Surg., May 1, 1997; 113(5): 836 - 848.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
Y. Tachimori, H. Kato, H. Watanabe, and H. Yamaguchi
Neck ultrasonography for thoracic esophageal carcinoma
Ann. Thorac. Surg., May 1, 1994; 57(5): 1180 - 1183.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Matsubara, M. Ueda, O. Yanagida, T. Nakajima, and M. Nishi
How extensive should lymph node dissection be for cancer of the thoracic esophagus?
J. Thorac. Cardiovasc. Surg., April 1, 1994; 107(4): 1073 - 1078.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. B. Skinner
Invited letter concerning: How extensive should lymph node dissection be for cancer of the thoracic esophagus?
J. Thorac. Cardiovasc. Surg., April 1, 1994; 107(4): 1154 - 1155.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
L. Berk and L. Coin
The role of neck dissection in thoracic esophageal cancer
Ann. Thorac. Surg., March 1, 1992; 53(3): 549 - 549.
[PDF]


Home page
Ann. Thorac. Surg.Home page
H. Kato
Reply
Ann. Thorac. Surg., March 1, 1992; 53(3): 549 - 550.
[PDF]


Home page
Ann. Thorac. Surg.Home page
D. B. Skinner
Cervical lymph node dissection for thoracic esophageal cancer
Ann. Thorac. Surg., June 1, 1991; 51(6): 884 - 885.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1991 by The Society of Thoracic Surgeons.